This session will explore the role of genomic variations in the development and progression of diabetes. Emphasis will be placed on identifying key genetic markers and their implications for disease susceptibility.

This track focuses on the impact of epigenetic changes on diabetes and its complications. Discussions will include how these modifications can inform personalized treatment strategies.

This session will delve into the cellular and molecular pathways that contribute to insulin resistance in diabetes. Researchers will present findings that highlight potential therapeutic targets for intervention.

This track aims to identify and validate biomarkers that can facilitate the early diagnosis of diabetes. Presentations will cover recent advancements in biomarker discovery and their clinical applications.

This session will discuss the integration of genomic data into personalized medicine for diabetes management. Participants will explore case studies that demonstrate the effectiveness of tailored treatment plans.

This track will examine the genetic epidemiology of diabetes across diverse populations. Insights into how population-specific factors influence disease prevalence and outcomes will be shared.